Editas Net Income from 2010 to 2026
| EDIT Stock | USD 1.73 0.05 2.81% |
Net Loss | First Reported 2014-03-31 | Previous Quarter -53.2 M | Current Value -25.1 M | Quarterly Volatility 20 M |
Check Editas Medicine financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Editas Medicine's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.5 M, Selling General Administrative of 55.2 M or Gross Profit of 39 M, as well as many indicators such as Price To Sales Ratio of 3.54, Dividend Yield of 0.0 or PTB Ratio of 0.74. Editas financial statements analysis is a perfect complement when working with Editas Medicine Valuation or Volatility modules.
Editas | Net Income | Build AI portfolio with Editas Stock |
The evolution of Net Income for Editas Medicine provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Editas Medicine compares to historical norms and industry peers.
Latest Editas Medicine's Net Income Growth Pattern
Below is the plot of the Net Income of Editas Medicine over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Editas Medicine financial statement analysis. It represents the amount of money remaining after all of Editas Medicine operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Editas Medicine's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Editas Medicine's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (237.09 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Editas Net Income Regression Statistics
| Arithmetic Mean | (110,262,895) | |
| Coefficient Of Variation | (74.21) | |
| Mean Deviation | 66,804,242 | |
| Median | (109,954,000) | |
| Standard Deviation | 81,831,483 | |
| Sample Variance | 6696.4T | |
| Range | 231.7M | |
| R-Value | (0.95) | |
| Mean Square Error | 653.1T | |
| R-Squared | 0.91 | |
| Slope | (15,446,446) | |
| Total Sum of Squares | 107142.3T |
Editas Net Income History
Other Fundumenentals of Editas Medicine
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Editas Medicine Net Income component correlations
About Editas Medicine Financial Statements
Editas Medicine shareholders use historical fundamental indicators, such as Net Income, to determine how well the company is positioned to perform in the future. Although Editas Medicine investors may analyze each financial statement separately, they are all interrelated. The changes in Editas Medicine's assets and liabilities, for example, are also reflected in the revenues and expenses on on Editas Medicine's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Loss | -213.4 M | -202.7 M | |
| Net Loss | -213.4 M | -224.1 M | |
| Net Loss | -198.4 M | -188.5 M | |
| Net Loss | (3.31) | (3.48) | |
| Net Income Per E B T | 0.91 | 0.81 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Editas Stock Analysis
When running Editas Medicine's price analysis, check to measure Editas Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Editas Medicine is operating at the current time. Most of Editas Medicine's value examination focuses on studying past and present price action to predict the probability of Editas Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Editas Medicine's price. Additionally, you may evaluate how the addition of Editas Medicine to your portfolios can decrease your overall portfolio volatility.